These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15475360)

  • 1. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
    del Re E; Sidis Y; Fabrizio DA; Lin HY; Schneyer A
    J Biol Chem; 2004 Dec; 279(51):53126-35. PubMed ID: 15475360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
    Chapman SC; Bernard DJ; Jelen J; Woodruff TK
    Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
    del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
    J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
    Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ; Vale WW
    Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
    Ethier JF; Farnworth PG; Findlay JK; Ooi GT
    Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
    Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inhibin signal transduction.
    Bernard DJ; Chapman SC; Woodruff TK
    Recent Prog Horm Res; 2001; 56():417-50. PubMed ID: 11237224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for a functional antagonist in the transforming growth factor beta superfamily.
    Cook RW; Thompson TB; Kurup SP; Jardetzky TS; Woodruff TK
    J Biol Chem; 2005 Dec; 280(48):40177-86. PubMed ID: 16186117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J; McKeehan K; Matsuzaki K; McKeehan WL
    J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a binding site on the type II activin receptor for activin and inhibin.
    Gray PC; Greenwald J; Blount AL; Kunitake KS; Donaldson CJ; Choe S; Vale W
    J Biol Chem; 2000 Feb; 275(5):3206-12. PubMed ID: 10652306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.
    Harrison CA; Gray PC; Fischer WH; Donaldson C; Choe S; Vale W
    J Biol Chem; 2004 Jul; 279(27):28036-44. PubMed ID: 15123686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
    J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
    Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
    Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.
    Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
    Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
    Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibin is an antagonist of bone morphogenetic protein signaling.
    Wiater E; Vale W
    J Biol Chem; 2003 Mar; 278(10):7934-41. PubMed ID: 12493742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).
    Chapman SC; Woodruff TK
    Mol Endocrinol; 2001 Apr; 15(4):668-79. PubMed ID: 11266516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
    Cheifetz S; Ling N; Guillemin R; Massagué J
    J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.